ASP-6858
- Generic Name
- ASP-6858
A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects
- First Posted Date
- 2015-02-09
- Last Posted Date
- 2016-06-21
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Target Recruit Count
- 88
- Registration Number
- NCT02359032
- Locations
- 🇬🇧
Site GB44001, Harrow, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath